Skip to main content
. 2023 Mar 17;58:101888. doi: 10.1016/j.eclinm.2023.101888

Fig. 3.

Fig. 3

Change in the intestinal microbiota composition from baseline at week 16. (a) PCoA plot based on Bray–Curtis dissimilarities of the faecal microbiota at genus level in terms of 16S rDNA sequencing between FMT (n = 31) and placebo (n = 32) groups, at baseline (left) and Week 16 (right), respectively. (b) PCoA plot based on Bray–Curtis dissimilarities of the faecal microbiota at genus level in terms of 16S rDNA sequencing between baseline (FMT group, n = 34; Placebo group, n = 34) and Week 16 (FMT group, n = 31; Placebo group, n = 32). (c) Bar charts of the LDA scores for differentially abundant bacterial taxa between baseline (FMT group, n = 34; Placebo group, n = 34) and Week 16 (FMT group, n = 31; Placebo group, n = 32). (LDA score threshold: >4.0). (d) Bar charts of the genus level in faecal samples based on 16S rDNA sequencing among Baseline-FMT (n = 34), Week 16-FMT (n = 31), Baseline-Placebo (n = 34), Week 16-Placebo (n = 32) groups. (e) Comparison of the relative abundance distributions of faecal microbiota genera between Baseline-FMT (n = 31) and Week 16-FMT (n = 31) groups (Wilcoxon matched-pairs signed rank test).